EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ ‐1 in melanoma

Agathe Quesnel, Leya Danielle Martin, Chaimaa Tarzi iD, Vasileios P Lenis iD, Nathan Coles, Meez Islam, Claudio Angione iD, Tiago F Outeiro, Ahmad A Khundakar, Panagiota S Filippou iD

Cancer Medicine · 2024-01 · 13 (1)

DOI: 10.1002/cam4.6900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 08.01.2024. Verfasst von Agathe Quesnel und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Life Sciences, Teesside University, Middlesbrough, UK. Hauptthemen laut MEDLINE: Protein Deglycase DJ-1, Melanoma, Skin Neoplasms, alpha-Synuclein. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Biochemical Society, Eric Reid Fund for Methodology Grant (for PSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Melanoma, the most lethal skin cancer type, occurs more frequently in Parkinson's disease (PD), and PD is more frequent in melanoma patients, suggesting disease mechanisms overlap. α‐synuclein, a protein that accumulates in PD brain, and the oncogene DJ‐1, which is associated with PD autosomal recessive forms, are both elevated in melanoma cells. Whether this indicates melanoma progression or constitutes a protective response remains unclear. We hereby investigated the molecular mechanisms through which α‐synuclein and DJ‐1 interact, suggesting novel biomarkers and targets in melanoma.

Methods

The Cancer Genome Atlas (TCGA) expression profiles derived from UCSC Xena were used to obtain α‐synuclein and DJ‐1 expression and correlated with survival in skin cutaneous melanoma (SKCM). Immunohistochemistry determined the expression in metastatic melanoma lymph nodes. Protein–protein interactions (PPIs) and molecular docking assessed protein binding and affinity with chemotherapeutic drugs. Further validation was performed using in vitro cellular models and ELISA immunoassays. Results α‐synuclein and DJ‐1 were upregulated in primary and metastatic SKCM. Aggregated α‐synuclein was selectively detected in metastatic melanoma lymph nodes. α‐synuclein overexpression in SK‐MEL‐28 cells induced the expression of DJ‐1, supporting PPI and a positive correlation in melanoma patients. Molecular docking revealed a stable protein complex, with differential binding to chemotherapy drugs such as temozolomide, dacarbazine, and doxorubicin. Parallel reduction of both proteins in temozolomide‐treated SK‐MEL‐28 spheroids suggests drug binding may affect protein interaction and/or stability. Conclusion α‐synuclein, together with DJ‐1, may play a role in melanoma progression and chemosensitivity, constituting novel targets for therapeutic intervention, and possible biomarkers for melanoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Deglycase DJ-1MelanomaSkin Neoplasmsalpha-SynucleinBiomarkers, TumorHumansCell Line, TumorMolecular Docking SimulationGene Expression Regulation, NeoplasticMaleLymphatic MetastasisProtein BindingFemale

Stichwörter der Autor:innen

DJ‐1chemotherapeutic drugsdiagnosismelanomamolecular dockingα‐Synuclein

Substanzen

Protein Deglycase DJ-1PARK7 protein, humanalpha-SynucleinBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Health & Life Sciences, Teesside University, Middlesbrough, UK.
  • National Horizons Centre, Teesside University, Darlington, UK.
  • School of Computing, Engineering & Digital Technologies, Teesside University, Middlesbrough, UK.
  • Centre for Digital Innovation, Teesside University, Middlesbrough, UK.
  • Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, University Medical Center, Göttingen, Germany.

ORCID-Profile: Chaimaa Tarzi, Vasileios P Lenis, Claudio Angione, Panagiota S Filippou

Förderung

  • Medical Research Council
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
  • Biochemical Society, Eric Reid Fund for Methodology Grant (for PSF)
  • Teesside University, Seed corn funding (for PSF)
  • Biochemical Society
  • Teesside University

Zitieren

APA

Quesnel, A., Martin, L. D., Tarzi, C., Lenis, V. P., Coles, N., Islam, M., Angione, C., Outeiro, T. F., Khundakar, A. A., & Filippou, P. S. (2024). Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ ‐1 in melanoma. Cancer Medicine, 13(1). https://doi.org/10.1002/cam4.6900

Vancouver

Quesnel A, Martin LD, Tarzi C, Lenis VP, Coles N, Islam M, et al. Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ ‐1 in melanoma. Cancer Medicine. 2024;13(1). doi:10.1002/cam4.6900

BibTeX
@article{Quesnel2024,
  author = {Quesnel, Agathe and Martin, Leya Danielle and Tarzi, Chaimaa and Lenis, Vasileios P and Coles, Nathan and Islam, Meez and Angione, Claudio and Outeiro, Tiago F and Khundakar, Ahmad A and Filippou, Panagiota S},
  title = {Uncovering potential diagnostic and pathophysiological roles of α‐synuclein and DJ ‐1 in melanoma},
  journal = {Cancer Medicine},
  year = {2024},
  volume = {13},
  number = {1},
  doi = {10.1002/cam4.6900}
}
Kostenlos starten →